The Claim
In a mouse model of dihydrotestosterone (DHT)-induced polycystic ovary syndrome (PCOS), daily oral administration of 1 × 10⁹ colony-forming units (CFU) of Bifidobacterium longum subsp. longum BL21 for 8 weeks was associated with reduced serum levels of pro-inflammatory markers (IL-6, TNF-α, and LPS) and increased levels of the anti-inflammatory cytokine IL-10, suggesting a potential role in mitigating chronic low-grade inflammation associated with PCOS.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Giving a specific gut bacteria to mice with a condition like PCOS helped lower their body's inflammation and boosted anti-inflammatory signals, which might help with the condition.
See the scientific wording
In a mouse model of DHT-induced PCOS, 8 weeks of daily oral administration of 1 × 10⁹ CFU of Bifidobacterium longum subsp. longum BL21 was associated with reduced serum levels of pro-inflammatory markers including IL-6, TNF-α, and LPS, and increased levels of anti-inflammatory IL-10, indicating a potential role in mitigating chronic low-grade inflammation associated with PCOS.
What the research says
1 studyThe study gave a specific probiotic to mice with PCOS for 8 weeks and found it reduced harmful inflammation and increased good anti-inflammatory signals, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.